Shared gene targets of the ATF4 and p53 transcriptional networks
Gabriele Baniulyte1, Serene A Durham1, Lauren E Merchant1
1Department of Biological Sciences and The RNA Institute, University at Albany, State University of New York, Albany, NY, USA.
Abstract:
The master tumor suppressor p53 regulates multiple cell fate decisions, like cell cycle arrest and apoptosis, via transcriptional control of a broad gene network. Dysfunction in the p53 network is common in cancer, often through mutations that inactivate p53 or other members of the pathway. Induction of tumor-specific cell death by restoration of p53 activity without off-target effects has gained significant interest in the field. In this study, we explore the gene regulatory mechanisms underlying a putative anti-cancer strategy involving stimulation of the p53-independent Integrated Stress Response (ISR). Our data demonstrate the p53 and ISR pathways converge to independently regulate common metabolic and pro-apoptotic genes. We investigated the architecture of multiple gene regulatory elements bound by p53 and the ISR effector ATF4 controlling this shared regulation. We identified additional key transcription factors that control basal and stress-induced regulation of these shared p53 and ATF4 target genes. Thus, our results provide significant new molecular and genetic insight into gene regulatory networks and transcription factors that are the target of numerous antitumor therapies.
Insights
This study reveals how the p53 and Integrated Stress Response (ISR) pathways independently control shared cancer-related genes. Understanding these networks offers new targets for cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The p53 tumor suppressor is crucial for cell fate decisions, and its network is frequently disrupted in cancer.
- Restoring p53 activity to induce tumor-specific cell death is a promising anti-cancer strategy.
- The Integrated Stress Response (ISR) pathway offers a p53-independent approach for cancer therapy.
Conclusions:
- The study provides novel molecular and genetic insights into gene regulatory networks.
- Identified transcription factors and regulatory mechanisms offer potential targets for anti-cancer therapies.
- Understanding the interplay between p53 and ISR pathways enhances knowledge of cancer biology and therapeutic strategies.
Related Concept Videos
Abnormal Proliferation
Master Transcription Regulators
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
General Transcription Factors
DNA Damage can Stall the Cell Cycle


